$DRUG

$51.09 -$1.39 (2.65%) Close

$DRUG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 7.6M shares outstanding

Who owns DRUG?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 722.6%

Ra Capital Management, L.P. 145.0% · BlackRock, Inc. 131.0%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

354

+9 vs last qtr

Net shares bought

+9.2M

by institutions in Q2 2026

New / sold out

70 / 61

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +2.2M
Jupiter Topco LLC NEW +1.4M

Biggest sellers in Q2 2026

Alyeska Investment Group, L.P. −1.5M
Janus Henderson Group PLC SOLD OUT −1.3M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Bright Minds Biosciences Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Bright Minds Biosciences Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years46% 3–5 years12% 1–3 years18% Under 1 year23%

Quarterly turnover

13.4%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting DRUG on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Ra Capital Management, L.P.	11.1M	144.98%	Unchanged	≤2021	0.4%
Shares held by quarter Peak holding11.3M (Q4'24) Change over 8 quarters+265.0K Share of the company144.980% Ra Capital Management, L.P.'s full portfolio →
B BlackRock, Inc.	10.0M	131.03%	+2.2M (+27.6%)	≤2021	0.0%
Shares held by quarter Peak holding10.0M (Q2'26) Change over 8 quarters+4.0M Share of the company131.030% BlackRock, Inc.'s full portfolio →

Ra Capital Management, L.P.

11.1M

% of company

144.98%

Change vs last qtr

Unchanged

Held since

≤2021

BlackRock, Inc.

10.0M

% of company

131.03%

Change vs last qtr

+2.2M (+27.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Bright Minds Biosciences Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DRUG on Form N-PORT; together they hold 294.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$150M	3.0M	38.78%	0.01%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$120M	2.3M	30.46%	0.14%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$150M

% of company

38.78%

% of the fund

0.01%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$120M

% of company

30.46%

% of the fund

0.14%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Bright Minds Biosciences Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
IM Ian McDonald 5%+ holder 13D · 13.7%	1.4M	18.29%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company18.290% Disclosed stake13D · 13.7% View the 13D/G filing →

Ian McDonald

5%+ holder13D · 13.7%

1.4M

% of company

18.29%

Change vs last qtr

—

Held since

—

Comments